Chloramphenicol Sodium Succinate from Canada
Water-soluble sodium succinate salt derivative of chloramphenicol, used for intravenous administration in critical infections. Falls under HTS 2941.40.00.00 as a salt of chloramphenicol per chapter note 5(C)(1) classifying organic salts with parent compounds. Essential for hospital antibiotic therapy.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include lyophilized vial specifications and reconstitution instructions; FDA requires bulk API sterility validation
• Monitor pH stability (6.4-7.2); improper storage causes succinate hydrolysis reverting to insoluble base
• Separate from human-use channels if veterinary grade to avoid FDA human drug import alerts